Promestriene

Generic Name
Promestriene
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C22H32O2
CAS Number
39219-28-8
Unique Ingredient Identifier
GXM4PER6WZ
Background

Promestriene (3-propyl ethyl, 17B-methyl estradiol) has been used in trials studying the prevention of Hypospadias. It is a synthetic estrogen analog, which is used in topical estrogen therapy. Promestriene’s potential for treating vaginal atrophy symptoms associated with aromatase inhibitor treatment would be precluded if its minimal absorption leads to est...

Indication

临床适用于雌激素缺乏性阴道萎缩和产后、手术或理疗时子宫阴道及外阴愈合迟缓。

Associated Conditions
Impaired Wound Healing, Vulvo Vaginal Atrophy
Associated Therapies
-
Clinical Trials
Related News

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

First Posted Date
2019-09-09
Last Posted Date
2023-09-14
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
195
Registration Number
NCT04081805
Locations
🇧🇷

Federal University of Sao Paulo - Unifesp, São Paulo, SP, Brazil

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

First Posted Date
2017-01-26
Last Posted Date
2019-05-01
Lead Sponsor
Universidade Federal do Paraná
Target Recruit Count
69
Registration Number
NCT03032848

Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications

First Posted Date
2011-06-10
Last Posted Date
2018-07-12
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
244
Registration Number
NCT01370798
Locations
🇫🇷

Hôpital Mère-Enfant, Nantes, France

🇫🇷

Hôpital NECKER, Paris, France

🇫🇷

Service de Chirurgie Pédiatrique Uro-génitale, Hopital femme Mere Enfant, Bron Cedex, France

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy